BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 32115350)

  • 1. Corrigendum to "Tanshinone IIA ameliorates the bleomycin-induced endothelial-to-mesenchymal transition via the Akt/mTOR/p70S6K pathway in a murine model of systemic sclerosis" [Int. Immunopharmacol. 77 (2019) 105968].
    Jiang Y; Hu F; Li Q; Shen C; Yang J; Li M
    Int Immunopharmacol; 2020 Jul; 84():106318. PubMed ID: 32115350
    [No Abstract]   [Full Text] [Related]  

  • 2. Tanshinone IIA ameliorates the bleomycin-induced endothelial-to-mesenchymal transition via the Akt/mTOR/p70S6K pathway in a murine model of systemic sclerosis.
    Jiang Y; Hu F; Li Q; Shen C; Yang J; Li M
    Int Immunopharmacol; 2019 Dec; 77():105968. PubMed ID: 31704290
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tanshinone IIA ameliorates bleomycin-induced pulmonary fibrosis and inhibits transforming growth factor-beta-β-dependent epithelial to mesenchymal transition.
    Tang H; He H; Ji H; Gao L; Mao J; Liu J; Lin H; Wu T
    J Surg Res; 2015 Jul; 197(1):167-75. PubMed ID: 25911951
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Corrigendum to "Sivelestat ameliorates sepsis-induced myocardial dysfunction by activating the PI3K/AKT/mTOR signaling pathway" [Int. Immunopharmacol. 128 (2024) https://doi.org/10.1016/j.intimp.2023.111466].
    Geng H; Zhang H; Cheng L; Dong S
    Int Immunopharmacol; 2024 Apr; 131():111873. PubMed ID: 38514302
    [No Abstract]   [Full Text] [Related]  

  • 5. Corrigendum to "Baccatin III ameliorates bleomycin-induced pulmonary fibrosis via suppressing TGF-β1 production and TGF-β1-induced fibroblasts differentiation" [Int Immunopharmacol. 74 (2019) 105696].
    Nie Y; Zhang D; Qian F; Wu Y
    Int Immunopharmacol; 2022 Mar; 104():108496. PubMed ID: 35016851
    [No Abstract]   [Full Text] [Related]  

  • 6. Corrigendum to "Tanshinone IIA analogue 15a inhibits NLRP3-mediated inflammation by activating mitophagy in macrophages to alleviate acute tubular necrosis" [Int. Immunopharmacol. 118 (2023) 110065].
    Chen J; Luo W; Hu C; Ren M; Xu H; Xu X; Li W; Chen Y; Shao J; Xiao Z; Lv X; Liang G
    Int Immunopharmacol; 2023 Aug; 121():110575. PubMed ID: 37407366
    [No Abstract]   [Full Text] [Related]  

  • 7. The combination of Nutlin-3 and Tanshinone IIA promotes synergistic cytotoxicity in acute leukemic cells expressing wild-type p53 by co-regulating MDM2-P53 and the AKT/mTOR pathway.
    Guo Y; Li Y; Wang FF; Xiang B; Huang XO; Ma HB; Gong YP
    Int J Biochem Cell Biol; 2019 Jan; 106():8-20. PubMed ID: 30389549
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tanshinone IIA protects against myocardial ischemia reperfusion injury by activating the PI3K/Akt/mTOR signaling pathway.
    Li Q; Shen L; Wang Z; Jiang HP; Liu LX
    Biomed Pharmacother; 2016 Dec; 84():106-114. PubMed ID: 27643552
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tanshinone IIA protects against heart failure post-myocardial infarction via AMPKs/mTOR-dependent autophagy pathway.
    Zhang X; Wang Q; Wang X; Chen X; Shao M; Zhang Q; Guo D; Wu Y; Li C; Wang W; Wang Y
    Biomed Pharmacother; 2019 Apr; 112():108599. PubMed ID: 30798134
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The activation of Akt/mTOR pathway by bleomycin in Epithelial-to-mesenchymal transition of human submandibular gland cells: A treatment mechanism of bleomycin for mucoceles of the salivary glands.
    Cai Y; Sun R; Wang R; Ren JG; Zhang W; Zhao YF; Zhao JH
    Biomed Pharmacother; 2017 Jun; 90():109-115. PubMed ID: 28343070
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Corrigendum to "Chondroprotective effects of Apolipoprotein D in knee osteoarthritis mice through the PI3K/AKT/mTOR signaling pathway" [Int. Immunopharmacol. 133 (2024) 112005].
    Zhang G; Huang C; Wang R; Guo J; Qin Y; Lv S
    Int Immunopharmacol; 2024 Jun; 134():112220. PubMed ID: 38734566
    [No Abstract]   [Full Text] [Related]  

  • 12. Corrigendum to "Emodin ameliorates ulcerative colitis by the flagellin-TLR5 dependent pathway in mice" [Int. Immunopharmacol. 59 (2018) 269-275].
    Luo S; Deng X; Liu Q; Pan Z; Zhao Z; Zhou L; Luo X
    Int Immunopharmacol; 2018 Sep; 62():337. PubMed ID: 29983242
    [No Abstract]   [Full Text] [Related]  

  • 13. Corrigendum to "Methyl helicterilate ameliorates alcohol-induced hepatic fibrosis by modulating TGF-β1/Smads pathway and mitochondria-dependent pathway" [Int. Immunopharmacol. 75 (2019) 105759].
    Wen S; Wei Y; Zhang X; Bai F; Tan S; Nie J; Wei J; Lin X
    Int Immunopharmacol; 2021 Mar; 92():107344. PubMed ID: 33418247
    [No Abstract]   [Full Text] [Related]  

  • 14. Nutlin-3 plus tanshinone IIA exhibits synergetic anti-leukemia effect with imatinib by reactivating p53 and inhibiting the AKT/mTOR pathway in Ph+ ALL.
    Guo Y; Li Y; Xiang B; Huang XO; Ma HB; Wang FF; Gong YP
    Biochem J; 2017 Dec; 474(24):4153-4170. PubMed ID: 29046392
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Corrigendum to "Single-cell RNA sequencing in double-hit lymphoma: IMPDH2 induces the progression of lymphoma by activating the PI3K/AKT/mTOR signaling pathway" [Int. Immunopharmacol. 125(Part A) (2023) 111125].
    Gao G; Xue Q; He J; Wu M; Jiang Y; Li Q; Zhang Y; Shi W
    Int Immunopharmacol; 2024 Jan; 126():111292. PubMed ID: 38042635
    [No Abstract]   [Full Text] [Related]  

  • 16. Inhibition of mTOR ameliorates bleomycin-induced pulmonary fibrosis by regulating epithelial-mesenchymal transition.
    Han Q; Lin L; Zhao B; Wang N; Liu X
    Biochem Biophys Res Commun; 2018 Jun; 500(4):839-845. PubMed ID: 29704504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Corrigendum to "Taxifolin ameliorates Benzo[a]pyrene-induced lung injury possibly via stimulating the Nrf2 signalling pathway" [Int. Immunopharmacol. 96 (2021) 107566].
    Islam J; Shree A; Vafa A; Afzal SM; Sultana S
    Int Immunopharmacol; 2023 Jun; 119():110096. PubMed ID: 37095029
    [No Abstract]   [Full Text] [Related]  

  • 18. Delicaflavone induces autophagic cell death in lung cancer via Akt/mTOR/p70S6K signaling pathway.
    Sui Y; Yao H; Li S; Jin L; Shi P; Li Z; Wang G; Lin S; Wu Y; Li Y; Huang L; Liu Q; Lin X
    J Mol Med (Berl); 2017 Mar; 95(3):311-322. PubMed ID: 27838742
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tanshinone IIA Protects Hippocampal Neuronal Cells from Reactive Oxygen Species Through Changes in Autophagy and Activation of Phosphatidylinositol 3-Kinase, Protein Kinas B, and Mechanistic Target of Rapamycin Pathways.
    Zhu Y; Tang Q; Wang G; Han R
    Curr Neurovasc Res; 2017; 14(2):132-140. PubMed ID: 28260507
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tanshinone IIA Induces Heme Oxygenase 1 Expression and Inhibits Cyclic Strain-Induced Interleukin 8 Expression in Vascular Endothelial Cells.
    Zhuang S; Cheng TH; Shih NL; Liu JC; Chen JJ; Hong HJ; Chan P
    Am J Chin Med; 2016; 44(2):377-88. PubMed ID: 27080946
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.